LEGAZPI CITY (PIA5) - An initial allocation of at least 12,000 doses of CoronaVac vaccine manufactured by Sinovac Biotech has arrived in Bicol region, Thursday morning.
The allocation is from the 600,000 doses of the coronavirus disease (COVID-19) vaccine donated by the Chinese Government that arrived on Sunday, February 28.
Dr. Ferchito Avelino, Department of Health (DOH)-5 Assistant Director, said in a media briefing that the region is included in the initial vaccination roll-out of the government where health workers from four pilot hospitals will receive the vaccine.
"There are at least 6,000 government health workers from the four hospitals allotted with the vaccines," Avelino said.
The official said that the priority hospitals for the vaccination rollout include the Bicol Regional Training and Teaching Hospital (BRTTH) in this city; Bicol Medical Center (BMC) in Naga City; Bicol Region General Hospital and Geriatric Medical Center in Cabusao, Camarines Sur; and the Naga Imaging Center Cooperative Doctors Hospital in Naga City.
He added that said hospitals served as COVID-19 treatment and isolation centers in Bicol.
Upon arrival, the vaccines were immediately inventoried and delivered to the facilities in Albay and Camarines Sur.
Avelino said the first doses will be administered to the health workers on March 5 and the next dose will be after 28 days.
He expressed confidence to the safety of vaccine and said that the best vaccine is the one that's available.
"Our government will not provide vaccines that will cause harm to its constituents," he added.
Further, he encouraged health workers to grab the oppurtunity to be inoculated while there is supply.
In an earlier press release by DOH Bicol, the priority for vaccination are frontline health workers (public and private whether permanent, contractual, or job-order employees or staff), indigent senior citizens, remaining indigent population, and uniformed personnel.
The DOH said the goal of prioritization is to maintain the most critical essential services; reduce morbidity and mortality; control transmission; minimize disruption of social, economic and security functions; and resumption to near normal. (PIA5)